$AMRN for those just waking up to this news. MTNB, ACST & generics are not threats... The only real threat was Epanova. Now that the STRENGTH trial has FAILED, this is a huge catalyst for AMRN. If the generics suit is settled before Wednesday (highly likely given the news that their lead counsel is gone), then the Analyst upgrades shall propel this to ALL TIME HIGHS this week, coupled with a short squeeze and a completely derisked stock which shall become the #1 buyout target after this news.